Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Pardoel, Soesja
DOB:	13-DEC-1961 (Age: 63)
Gender:	female
Address:	Eemnesserweg 107 1251 NA Laren (Netherlands)
ID:	3706-987673-0

Report
Date:	02-JUL-2025

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
Gezondheidscentrum Vizier 1315 Almere-Stad (Netherlands)

Specimen
Collected:	01-JUL-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Hematology

Test	01 Jul 2025	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	1.6 L	3.6 - 10.5	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.4	4.2 - 5.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	7.2 L	12 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	33.6 L	38 - 46	%
MCV [Entitic volume] by Automated count	81.8 L	82 - 98	fL
MCH [Entitic mass] by Automated count	29.5	27 - 34	pg
MCHC [Mass/volume] by Automated count	34.3	31 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	41.7	36 - 56	fL
Platelets [#/volume] in Blood by Automated count	303.9	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	256.1	150 - 450	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	9.6	7.4 - 12	fL

Chemistry

Test	01 Jul 2025	Reference Range	Unit
Glucose [Mass/volume] in Blood	67.7 L	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	11.6	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	2.8 H	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.4	8.5 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	137.1	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.4	3.5 - 5	mmol/L
Chloride [Moles/volume] in Blood	109.4 H	101 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	24.1	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.0	6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.4	3.5 - 5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.9	2 - 3.5	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	1.0	0.3 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	24.7 L	44 - 104	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	46.3 H	5 - 34	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	21.0	10 - 40	U/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistent renal dysfunction (elevated creatinine), chronic anemia (low hemoglobin, hematocrit), and leukopenia. There is mild, fluctuating hypoglycemia and occasional mild transaminase elevation. Electrolytes and liver synthetic function are largely preserved. The findings suggest chronic kidney disease with associated anemia and possible bone marrow suppression; further clinical correlation and hematology/nephrology evaluation are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistent renal dysfunction (elevated creatinine), chronic anemia (low hemoglobin, hematocrit), and leukopenia. There is mild, fluctuating hypoglycemia and occasional mild transaminase elevation. Electrolytes and liver synthetic function are largely preserved. The findings suggest chronic kidney disease with associated anemia and possible bone marrow suppression; further clinical correlation and hematology/nephrology evaluation are recommended.